Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A M van Laar

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Medicine & Research|January 11, 2007
Cytokines in uveitisJ A M van Laar, P M van Hagen
The Netherlands Journal of Medicine|June 20, 2015
Treatment of multicentric Castleman’s disease in HIV-1 infected and uninfected patients: a systematic reviewC Rokx, B J A Rijnders, J A M van Laar
The Netherlands Journal of Medicine|December 22, 2015
A relapsing swelling of the nasal tipF R Datema, R M L Poublon, J A M van Laar
Seminars in Arthritis and Rheumatism|January 17, 2022
Immunopathogenesis of Behçet's disease and treatment modalitiesT B van der Houwen, P M van Hagen, J A M van Laar
Clinical and Experimental Dermatology|September 22, 2018
The histological absence of IgG4 positive plasma cells in juvenile xanthogranuloma; comments on 'Systemic juvenile xanthogranuloma: a case report and brief review'S E Detiger, A F Karim, J A M van Laar, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
A non-radioactive sensitive assay to measure 5-fluorouracil incorporation into DNA of solid tumorsP Noordhuis, U Holwerda, J A M Van Laar, et al.
International Ophthalmology|June 22, 2018
The tarsal plate manifestation of IgG4-related diseaseJ S N Verhoekx, A F Karim, J A M van Laar, et al.
The Netherlands Journal of Medicine|March 30, 2016
An inflammatory condition with different faces: immunoglobulin G4-related diseaseA F Karim, R M Verdijk, J Guenoun, et al.
Orbit (Amsterdam, Netherlands)|April 21, 2026
Adnexal necrobiotic xanthogranuloma presenting as a "kissing" eyelid lesionM A Suadi, S E Detiger, D Scheers, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 21, 2006
[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication]J A M van Laar, A Jamnitski, G S Baarsma, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Medicine & Research|January 11, 2007
Cytokines in uveitisJ A M van Laar, P M van Hagen
The Netherlands Journal of Medicine|June 20, 2015
Treatment of multicentric Castleman’s disease in HIV-1 infected and uninfected patients: a systematic reviewC Rokx, B J A Rijnders, J A M van Laar
The Netherlands Journal of Medicine|December 22, 2015
A relapsing swelling of the nasal tipF R Datema, R M L Poublon, J A M van Laar
Seminars in Arthritis and Rheumatism|January 17, 2022
Immunopathogenesis of Behçet's disease and treatment modalitiesT B van der Houwen, P M van Hagen, J A M van Laar
Clinical and Experimental Dermatology|September 22, 2018
The histological absence of IgG4 positive plasma cells in juvenile xanthogranuloma; comments on 'Systemic juvenile xanthogranuloma: a case report and brief review'S E Detiger, A F Karim, J A M van Laar, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
A non-radioactive sensitive assay to measure 5-fluorouracil incorporation into DNA of solid tumorsP Noordhuis, U Holwerda, J A M Van Laar, et al.
International Ophthalmology|June 22, 2018
The tarsal plate manifestation of IgG4-related diseaseJ S N Verhoekx, A F Karim, J A M van Laar, et al.
The Netherlands Journal of Medicine|March 30, 2016
An inflammatory condition with different faces: immunoglobulin G4-related diseaseA F Karim, R M Verdijk, J Guenoun, et al.
Orbit (Amsterdam, Netherlands)|April 21, 2026
Adnexal necrobiotic xanthogranuloma presenting as a "kissing" eyelid lesionM A Suadi, S E Detiger, D Scheers, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 21, 2006
[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication]J A M van Laar, A Jamnitski, G S Baarsma, et al.
Pageof 3